piggyBac transposon system modification of primary human T cells.
about
Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.Endogenous Transposase Source in Human Cells Mobilizes piggyBac Transposons.
P2860
piggyBac transposon system modification of primary human T cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
piggyBac transposon system modification of primary human T cells.
@en
piggyBac transposon system modification of primary human T cells.
@nl
type
label
piggyBac transposon system modification of primary human T cells.
@en
piggyBac transposon system modification of primary human T cells.
@nl
prefLabel
piggyBac transposon system modification of primary human T cells.
@en
piggyBac transposon system modification of primary human T cells.
@nl
P2093
P2860
P356
P1476
piggyBac transposon system modification of primary human T cells.
@en
P2093
Cliona M Rooney
Daniel L Galvan
Joseph E Doherty
Leslie E Huye
Matthew H Wilson
Yozo Nakazawa
P2860
P356
10.3791/4235
P577
2012-11-05T00:00:00Z